ALS medication AMX0114 has been well tolerated in early clinical testing, and is now moving to a second, higher-dose trial ...

While briefly changing roles with her husband, columnist Kristin Neva got a glimpse of how frustrating it is to have difficulty speaking.

Neurosense Therapeutics said it will seek conditional approval of PrimeC as an ALS treatment in Canada in mid-2006.

Using adaptive tools and following ALS kitchen safety strategies can make cooking and eating safer when living with ALS.

Slowing down in a fast-paced world while living with ALS isn’t surrendering, writes columnist. It’s an active choice to be ...

Actor Eric Dane is joining nonprofit Target ALS on a campaign aiming to raise $500,000 for ALS research by Dec. 31.

The ALS Association awarded a $1 million grant to support a clinical trial testing Pasithea's MEK inhibitor PAS-004 in people ...

So what happens now? All of a sudden, I was on my own, left to navigate my world, which had changed forever. I was restless, not quite knowing what to do with myself or how to fill my time. I’d just ...

The FDA has authorized a Phase 3 trial of PrimeC, an experimental oral therapy for ALS. In a prior Phase 2b study, PrimeC slowed ALS progression by 37.4% and improved survival by 43% in key patient ...